{"changes":[{"companyHref":"/c/granata-bio","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1773867/000177386724000001/primary_doc.xml","domain":"granata.bio","fact":"latest round","name":"GRANATA BIO Corp","new":{"amountUsd":13800000,"date":"2024-12-19","lead":null,"type":null},"old":{"amountUsd":13800000,"date":"2024-12-19","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"granata-bio","status":"sourced","url":"https://whoraisedwhat.com/c/granata-bio"},{"companyHref":"/c/granata-bio","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1773867/000177386724000001/primary_doc.xml","domain":"granata.bio","fact":"provenance:round","name":"GRANATA BIO Corp","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1773867/000177386724000001/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"granata-bio","status":"sourced","url":"https://whoraisedwhat.com/c/granata-bio"}],"country":"US","description":"Granata Bio identifies and develops fertility medications for the North American IVF market across ovarian stimulation, trigger shots, and luteal phase support. It serves US fertility clinics, IVF patients, and pharma partners looking for a specialist commercial channel. Leadership brings 130+ combined years in reproductive health regulatory and commercialization.","domain":"granata.bio","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":"granata","githubStars":2,"industry":"bio","investors":[],"lat":42.04177,"lng":-70.672259,"location":"Duxbury, MA","name":"GRANATA BIO Corp","rounds":[{"amountQuarantined":false,"amountUsd":13800000,"currency":"USD","date":"2024-12-19","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1773867/000177386724000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1773867/000177386724000001/primary_doc.xml"}],"slug":"granata-bio","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1773867/000177386724000001/primary_doc.xml"},{"fact":"existence","publisher":"granata.bio","retrievedAt":"2026-05-05","status":"self-reported","url":"https://granata.bio"},{"fact":"description","publisher":"granata.bio","retrievedAt":"2026-05-05","status":"self-reported","url":"https://granata.bio"}],"stage":null,"techStack":["Typekit","Adobe Fonts","Afterpay","Sentry","Squarespace","Squarespace Commerce","Stimulus","web-vitals","moment 0","lodash .","@sentry/browser","React"],"totalRaisedUsd":13800000,"updatedAt":"2026-05-05"}